Esophageal Adenocarcinoma Methods and Protocols

(sharon) #1
49

chest drain, which may be turbid in color, lead to diagnosis.
The location and magnitude of the leak can be visualized by a
water-soluble contrast study. A carefully performed flexible
endoscopic examination is also helpful. For small contained
leaks, CT-guided drainage of pockets of collection may suffice.
In septic patients with a sizable leak, exploration is warranted.
Direct repair is seldom possible or effective, drainage is the key.
Injection of fibrin glue or placement of intraluminal stents is
increasingly used to treat leaks, sealing of the leak allows early
control of sepsis and resumption of oral alimentation. The
stent can be removed afterward, depending on the severity of
the leak in the first place. Usually, 4–6 weeks will suffice for
adequate healing.


  1. Delayed gastric emptying. A routine pyloric drainage procedure
    is helpful but does not eliminate this complication because of
    other contributory factors. Malrotation of the gastric conduit is
    rare but is serious and should prompt immediate re-explora-
    tion. A larger gastric tube has more tendency of gastric reten-
    tion, especially when an Ivor-Lewis operation is performed; the
    redundant part of the stomach tends to form a pocket above
    the diagram, which turns anteriorly and medially before coming
    through the diaphragmatic hiatus into the abdomen. The stom-
    ach placed in the retrosternal route (when a cervical anastomo-
    sis is elected) also has less change of delayed emptying.


References



  1. Siewert JR, Stein HJ (1998) Classification of
    adenocarcinoma of the esophagogastric junction
    [see comments]. Br J Surg 85(11):1457–1459

  2. Omloo JM, Lagarde SM, Hulscher JB, Reitsma
    JB, Fockens P, van Dekken H, ten Kate FJ,
    Obertop H, Tilanus HW, van Lanschot JJ
    (2007) Extended transthoracic resection com-
    pared with limited transhiatal resection for
    adenocarcinoma of the mid/distal esophagus:
    five-year survival of a randomized clinical trial.
    Ann Surg 246(6):992–1000

  3. Sasako M, Sano T, Yamamoto S, Sairenji M,
    Arai K, Kinoshita T, Nashimoto A, Hiratsuka
    M (2006) Left thoracoabdominal approach
    versus abdominal-transhiatal approach for gas-
    tric cancer of the cardia or subcardia: a ran-
    domised controlled trial. Lancet Oncol
    7(8):644–651

  4. Law S (2012) Esophagogastrectomy for carci-
    noma of the esophagus. In: Fischer J (ed)
    Mastery of surgery, 6th edn. Wolters Kluweer,
    Lippincott Williams & Wilkins, Philadelphia,
    pp 886–903

  5. Shapiro J, van Lanschot JJ, Hulshof MC, van
    Hagen P, van Berge Henegouwen MI,


Wijnhoven BP, van Laarhoven HW,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp
JJ, Cuesta MA, Blaisse RJ, Busch OR, Ten Kate
FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul
HM, Bilgen EJ, van Dekken H, van der Sangen
MJ, Rozema T, Biermann K, Beukema JC, Piet
AH, van Rij CM, Reinders JG, Tilanus HW,
Steyerberg EW, van der Gaast A, group Cs
(2015) Neoadjuvant chemoradiotherapy plus
surgery versus surgery alone for esophageal or
junctional cancer (CROSS): long- term results
of a randomised controlled trial. Lancet Oncol
16(9):1090–1098. https://doi.org/10.1016/
S1470-2045(15)00040-6


  1. van Hagen P, Hulshof MC, van Lanschot JJ,
    Steyerberg EW, van Berge Henegouwen MI,
    Wijnhoven BP, Richel DJ, Nieuwenhuijzen
    GA, Hospers GA, Bonenkamp JJ, Cuesta MA,
    Blaisse RJ, Busch OR, ten Kate FJ, Creemers
    GJ, Punt CJ, Plukker JT, Verheul HM,
    Spillenaar Bilgen EJ, van Dekken H, van der
    Sangen MJ, Rozema T, Biermann K, Beukema
    JC, Piet AH, van Rij CM, Reinders JG, Tilanus
    HW, van der Gaast A, Group C (2012)
    Preoperative chemoradiotherapy for esopha-


Surgery for Esophageal Adenocarcinoma
Free download pdf